These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4149045)

  • 41. [Malignant hyperthermia. Report of a case].
    Marín Ruiz R; Zepeda J
    Ginecol Obstet Mex; 1983 Sep; 51(317):241-4. PubMed ID: 6681307
    [No Abstract]   [Full Text] [Related]  

  • 42. [Malignant hyperpyrexia: a frequently unrecognized complication of anesthesia].
    Hoevenaars F; Sengers RC; Stadhouders AM; Gielen MJ; Brunings WL; Trijbels JM; Bookelman H
    Ned Tijdschr Geneeskd; 1977 Jun; 121(24):976-81. PubMed ID: 876426
    [No Abstract]   [Full Text] [Related]  

  • 43. Malignant hyperpyrexia--the difficulty of diagnosis.
    Jago RH; Payne MJ
    Anaesthesia; 1976 Sep; 31(7):955-6. PubMed ID: 970594
    [No Abstract]   [Full Text] [Related]  

  • 44. [Congenital fiber-type disproportion and fixed lumbar lordosis].
    Hiedl P; Glas K; Hofmann HJ
    Z Orthop Ihre Grenzgeb; 1982; 120(6):767-9. PubMed ID: 7164537
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant hyperthermia: screening of a family by serum-enzymes, electromyography and nerve-conduction.
    Kratholm S; Nielsen E
    Anaesth Resusc Intensive Ther; 1974; 2(4):359-63. PubMed ID: 4460754
    [No Abstract]   [Full Text] [Related]  

  • 46. King's syndrome with malignant hyperthermia. Potential outpatient risks.
    Steenson AJ; Torkelson RD
    Am J Dis Child; 1987 Mar; 141(3):271-3. PubMed ID: 3812408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives.
    Isaacs H; Barlow MB
    Br J Anaesth; 1970 Dec; 42(12):1077-84. PubMed ID: 5504449
    [No Abstract]   [Full Text] [Related]  

  • 48. [Two cases of subclinical myopathy. Is it a trait for malignant hyperthermia? (author's transl)].
    Sunohara N; Takagi A; Nonaka I; Satoyoshi E; Kojima S
    Rinsho Shinkeigaku; 1980 Jun; 20(6):448-54. PubMed ID: 7408344
    [No Abstract]   [Full Text] [Related]  

  • 49. Treatment of dorsal kyphosis with the Milwaukee brace.
    Ravaglia L; Caruso G
    Ital J Orthop Traumatol; 1981 Apr; 7(1):61-70. PubMed ID: 7327931
    [No Abstract]   [Full Text] [Related]  

  • 50. Malignant hyperpyrexia: an anaesthetic hazard.
    Jaffe EC; Wedley JR
    Br Dent J; 1972 Dec; 133(12):538-41. PubMed ID: 4511819
    [No Abstract]   [Full Text] [Related]  

  • 51. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.
    Isaacs H; Heffron JJ
    Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies.
    McPherson EW; Taylor CA
    Am J Med Genet; 1981; 8(2):159-65. PubMed ID: 7282770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignant hyperpyrexia: Investigation of a family after a fatal case.
    Ryan DW; Appleyard TN
    Br J Anaesth; 1975 Sep; 47(9):1001-4. PubMed ID: 1191461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Goniometer evaluation of thoracic kyphosis and lumbar lordosis in subjects during growth age: a validity study.
    Gravina AR; Ferraro C; Frizziero A; Ferraro M; Masiero S
    Stud Health Technol Inform; 2012; 176():247-51. PubMed ID: 22744501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postoperative malignant hyperthermia: a case report.
    Beldavs J; Small V; Cooper DA; Britt BA
    Can Anaesth Soc J; 1971 Mar; 18(2):202-12. PubMed ID: 5572702
    [No Abstract]   [Full Text] [Related]  

  • 56. [Malignant hyperthermia. 2 unusual courses].
    Harnisch R; Abigt J; Kohne E; Hörder MH
    Intensivmed Prax; 1980; (2):59-66. PubMed ID: 7450881
    [No Abstract]   [Full Text] [Related]  

  • 57. Elevated serum-creatine phosphokinase activity in a family with malignant hyperpyrexia.
    Zsigmond EK; Starkweather WH; Duboff GS; Flynn K
    Anesth Analg; 1972; 51(2):220-5. PubMed ID: 5062123
    [No Abstract]   [Full Text] [Related]  

  • 58. Salicylate toxicity masquerading as malignant hyperthermia.
    Candy JM; Morrison C; Paton RD; Logan RW; Lawson R
    Paediatr Anaesth; 1998; 8(5):421-3. PubMed ID: 9742539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Muscular enzyme level disorders and a malignant hyperthermia susceptability test: postoperative study of a patient with elevated CPK].
    Perugini M; Montironi C; Rocchi S
    Minerva Anestesiol; 1998; 64(1-2):45-50. PubMed ID: 9658790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Malignant hyperpyrexia due to general anaesthesia with a possible relation to primary muscle disease].
    Gjengstö H; Myking AO
    Anaesthesist; 1971 Aug; 20(8):306-9. PubMed ID: 5570379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.